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Department of Bioinformatics and Computational Biology, George Mason University, Manassas, VirginiaABSTRACT Although the oligomers formed by Ab peptides appear to be the primary cytotoxic species in Alzheimer’s disease,
detailed information about their structures appears to be lacking. In this article, we use exhaustive replica exchange molecular
dynamics and an implicit solvent united-atom model to study the structural properties of Ab monomers, dimers, and tetramers.
Our analysis suggests that the conformational ensembles of Ab dimers and tetramers are very similar, but sharply distinct from
those sampled by the monomers. The key conformational difference between monomers and oligomers is the formation of
b-structure in the oligomers occurring together with the loss of intrapeptide interactions and helix structure. Our simulations indi-
cate that, independent of oligomer order, the Ab aggregation interface is largely confined to the sequence region 10–23, which
forms the bulk of interpeptide interactions. We show that the fractions of b structure computed in our simulations and measured
experimentally are in good agreement.INTRODUCTIONAberrant aggregation of polypeptide chains and subsequent
amyloid fibril formation are linked to more than 20 various
medical disorders, including Alzheimer’s, Parkinson’s, and
Creutzfeldt-Jakob diseases (1). Biomedical experiments
and genetic studies suggested that the onset of Alzheimer’s
disease is related to extracellular aggregation of Ab peptides
(2), which are produced by natural cleavage of the trans-
membrane amyloid precursor protein. Although these
peptides have varying lengths, the 40-residue species,
Ab1–40, are most abundant. Their assembly into amyloid
fibrils is a multistage conformational transition, in which
mobile oligomeric species appear as intermediates on the
pathway leading to mature fibrils (3–7). It has been long
known that Ab fibrils are cytotoxic (8), but recent findings
pointed to Ab oligomers as primary cytotoxic species in
Alzheimer’s disease (9,10). Furthermore, synaptic structure
and function can be impaired even by the smallest Ab
oligomers, dimers (11). According to hydrogen/deuterium
exchange experiments, soluble oligomeric species exist in
dynamic equilibrium with amyloid fibrils (12). These obser-
vations implicate a crucial role played by Ab oligomers in
amyloidogenesis.
A number of experimental studies have been focused
on elucidating the structures of Ab monomers. In aqueous
solution, they are largely random, lacking stable secondary
or tertiary structures (13–15). Solid-state NMR experiments
have probed the endproducts of amyloid assembly, Ab
fibrils, revealing in-registry parallel b-sheet structure
(16–18). In contrast to Ab monomers or fibrils, there is
a lack of structural information on Ab oligomers. At micro-
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0006-3495/10/09/1949/10 $2.00Ab oligomers coexist with monomers (19) and demonstrate
a distinctive size distribution existing predominantly as
dimers, trimers, or tetramers (20). Higher order (n> 4) olig-
omers have significantly smaller frequency of occurrence.
Molecular dynamics (MD) simulations, which probe Ab
amyloid formation at all-atom resolution, can provide impor-
tant structural information supplemental to the experiments
(21). For example, conformational ensembles sampled by
Ab1–40 monomer (22,23) and its fragments (24,25) have
been investigated. A full-length Ab1–40 was shown to have
several structured regions, including short b-strands, helices,
and b-turns, in generally random coil-like ensemble of
conformations (22,23). MD simulations of Ab oligomers,
which are more computationally intensive, have been
recently reported (26–31). In general, these studies have
shown that aggregation leads to conformational changes
in Ab peptides with respect to monomeric species. For
example, we have previously shown that interpeptide interac-
tions in Ab dimers shift the distribution of secondary struc-
ture, from helical states toward b-strand conformations (28).
Nevertheless, many questions concerning the oligomer
structure remain unexplored. For example (1), what is the
distribution of conformations sampled by individual Ab
peptides in the oligomers? It is challenging to obtain this
information in the experiments, which report the bulk
averages of structural quantities (2). Are there differences
between the conformational ensembles of oligomers of
different orders and between those of oligomers and mono-
mers? In other words, how does the structure of Ab peptides
change with the progression of aggregation from monomers
to, say, tetramers?
To answer these questions, we use exhaustive replica ex-
change MD (REMD) and an implicit solvent united-atom
model to study the structural properties of Ab monomers,
dimers and tetramers. Because dimers and tetramersdoi: 10.1016/j.bpj.2010.07.008
1950 Kim et al.represent the most abundant Ab oligomers, some tentative
conclusions about Ab oligomers and their comparison with
the monomers can be made. In this work we use the N-ter-
minal truncated fragment of the full-length peptide, Ab10–40
(Fig. 1 a). According to the experiments (15,17,32,33) and
simulations (28,34) truncation of the first nine N-terminal
amino acids results in minor changes in the conformational
ensembles of Ab monomers, oligomers, and fibrils (see the
Supporting Material for details). Consequently, we use
Ab10–40 as a model of the full-length Ab1–40 peptide.
First, we show that the distributions of Ab peptide confor-
mations are similar in dimers and tetramers, but are sharply
different from those sampled in monomeric species.
Second, the oligomer conformational ensemble is charac-
terized by fewdistinct structural basins, inwhich themajority
of Ab peptides reside. These basins differ with respect to the
distribution of secondary structure and the amount of inter-
and intrapeptide interactions. Nt
a Y10EVHHQKLVFF20AEDVGSNKGA30IIGLMVGG
b
 Ct
c
d
Biophysical Journal 99(6) 1949–1958Third, our simulations suggest that independent of
oligomer order n, the Ab aggregation interface is largely
confined to the sequence region 10–23, which forms the
bulk of interpeptide interactions. We conclude the article
by comparing the computational and experimental distribu-
tions of secondary structure.METHODS
Simulation model
To probe the conformational ensembles of Ab peptides, we employed the
CHARMM MD program (35), the united-atom force field CHARMM19,
and the SASA implicit solvent model (36). The description of the
CHARMM19þSASA model and its testing were reported in our previous
studies (28,34,37,38). In recent years, the CHARMM19þSASA model
has been used in protein folding simulations (39,40) and to study aggrega-
tion of amyloidogenic peptides (41,42). Arguments supporting the use of
CHARMM19þSASA implicit solvent model are presented in the Support-
ing Material.VV40
FIGURE 1 (a) The sequence of Ab10–40 peptide
and the allocation of the N-terminal Nt and
C-terminal Ct regions. (b–d) Three Ab10–40 species
studied in our simulations: (b) monomer, (c) dimer,
and (d) tetramer. The N- and C-terminals are
colored in shades of red and yellow, respectively.
The Nt region tends to form most of the interpeptide
interactions. The structures are visualized using
Chimera (50).
Conformational Ensembles of Ab Oligomers 1951Three Ab10–40 systems—monomer, dimer, and tetramer—were consid-
ered (Fig. 1). Their description can be found in our previous studies
(28,34,43). Briefly, the monomer, dimer, and tetramer systems involve
one, two, or four identical unconstrained Ab10–40 peptides, respectively.
The simulation systems utilized spherical boundary condition with the
radius Rs ¼ 90 A˚ and the force constant ks¼ 10 kcal/(mol A˚2). The concen-
tration of Ab peptides was therefore on the order of mM. Because in vitro
Ab peptides exist predominantly in the form of monomers through tetra-
mers (20), the three in silico systems represent the most abundant Ab
species (excluding the trimers).Replica exchange simulations
Conformational sampling was performed using replica exchange molecular
dynamics (REMD) (44). The description of REMD implementation can be
found in our previous studies (28,34). Briefly, 24 replicas were distributed
linearly in the temperature range from 300 to 530 K with the increment of
10K. The temperature range spans the spectrum ofAb conformational states
from aggregated (or collapsed) to completely dissociated (or open). Due to
small temperature increments, the energy distributions from neighboring
replicas share significant overlap. The exchanges were attempted every
80 ps between all neighboring replicas with the average acceptance rate of
67% (monomer), 54% (dimer), and 38% (tetramer). In all, four (monomer),
seven (dimer), or eight (tetramer) REMD trajectories were produced result-
ing in the cumulative simulation times of 76 (monomer), 134 (dimer), and
154 ms (tetramer). The structures were saved every 40 ps. Between replica
exchanges, the systemevolved usingNVTunderdampedLangevin dynamics
with the damping coefficient g ¼ 0.15 ps–1 and the integration step of 2fs.
Because the initial parts of REMD trajectories are not equilibrated and
must be excluded from thermodynamic analysis, the cumulative equilibrium
simulation timewas reduced to tsimz 72,z113, andz126 ms. The REMD
trajectories were started with random distributions of peptides in the sphere
equilibrated at 600 K. In the initial structures, all peptides were dissociated.Computation of structural probes
The interactions formed in Ab peptides and oligomers were analyzed by
considering side-chain contacts and hydrogen bonds (HBs). A side-chain
contact is formed, if the distance between the centers of mass of side chains
is <6.5A˚. Two peptides are considered aggregated, if there is at least one
side-chain contact between them. Backbone HBs between NH and CO
groups were assigned according to Kabsch and Sander (45). We defined
two classes of interpeptide backbone HBs. The first includes any HBs
between the peptides. The second class is restricted to parallel b-sheet
HBs. A parallel HB (pHB) is formed between the residues i and j, if at least
one other HB is also present between i þ 2 and j or j þ 2 (or between i – 2
and j or j – 2). The definition of pHB follows from the structural analysis of
parallel b-sheets. Secondary structure in Ab peptides was computed using
the distribution of (f, j) backbone dihedral angles. Specific definitions of
b-strand and helix states can be found in our previous studies (28).
Throughout this article, angle brackets h.i imply thermodynamic
averages. Because dimer and tetramer include several indistinguishable
peptides, we report averages over two and four peptides, respectively.
The distributions of states produced by REMD were analyzed using
multiple histogram method (46). The convergence of REMD simulations
and error analysis were reported in our previous studies (28,43). In partic-
ular, the thermodynamic quantities probing inter- and intrapeptide interac-
tions have the errors of 1% (tetramer) and( 4% (dimer or monomer). The
errors in computing the conformational states of individual residues did not
exceed 7% for the tetramer and monomer and 8% for the dimer.FIGURE 2 Assembly of Ab10–40 tetramer is probed by the thermal
averages of the numbers of interpeptide side-chain contacts hC(T)i (solid
line) and HBs hNhb(T)i (dashed line) as a function of temperature. The
plot demonstrates the formation of Ab10–40 tetramer with the decrease in
temperature.Cluster analysis of Ab conformations
The cluster analysis of Ab peptide conformations is described in the Sup-
porting Material.RESULTS
The conformational ensembles of Ab10–40 monomers,
dimers, and tetramers were investigated using REMD simu-
lations (Fig. 1). Before presenting the results, it is useful to
define the sequence regions in Ab peptide. Following
the experimental Ab fibril structure (17), we distinguish the
N-terminal (Nt, residues 10–23), which corresponds to the
first fibril b-strand, and the C-terminal (Ct, residues 29–39),
which corresponds to the second fibril b-strand (Fig. 1 a). All
thermodynamic quantities for Ab oligomers and monomers
are reported at the temperature 360 K, at which Ab peptide
locks into fibril-like state during fibril growth (37,42). The
selection of this temperature facilitates the comparison of
conformational changes occurring upon aggregation, up to
the deposition of Ab peptides into the fibril.Conformational propensities of Ab oligomers
and monomers
To probe the formation of Ab oligomers we computed
the numbers of interpeptide side-chain contacts hC(T)i and
hydrogen bonds (HBs) hNhb(T)i formed by a peptide
with other chains in the oligomer. Their temperature
dependences shown in Fig. 2 indicate that the number of
interpeptide interactions increases with the decrease in
temperature T. At 360 K, the number of interpeptide contacts
hCi for the tetramer is 55.1, whereas interpeptide HBs
(hNhbi z 6.3) are relatively few (Table 1). Furthermore,
tetramer almost completely lacks pHBs, which probe the
formation of parallel b-sheets (hNphbiz 0.8). Ab peptide in
the tetramer also forms a large number of intrapeptide
interactions. For example, the numbers of intrapeptide side-
chain contacts and HBs are hCii z 25.7 and hNihbi z 8.0,Biophysical Journal 99(6) 1949–1958
TABLE 1 Ab10–40 structural characteristics
Ab species hCi hNhbi hSi* hHiy hCii hNihbi Sexpz
Monomer (1)x — — 0.24 (0.17,0.29) 0.32 (0.51,0.15) 32.2 14.1 0.24
Dimer (2)x 30.0{ 3.7 0.37 (0.36,0.36) 0.21 (0.32,0.11) 24.2 9.4 0.39
Tetramer (4)x 55.1 6.3 0.39 (0.37,0.38) 0.20 (0.31,0.10) 25.7 8.0 0.45
Fibril (N)x 0.52k 0.57
*Numbers in parentheses are the fractions of b-structure in the Nt and Ct regions, respectively.
yNumbers in parentheses are the fractions of helix in the Nt and Ct regions, respectively.
zExperimental fraction of b-structure from Ono et al. (20).
xOligomer order n. Monomer has n ¼ 1.
{Data from Takeda and Klimov (34,47).
kData from Takeda and Klimov (42).
1952 Kim et al.respectively (Table 1). The probability of forming a tetramer
at 360 K isz 1.0 (see Discussion).
With respect to the tetramer, Ab peptide in the dimer is
engaged in fewer interpeptide interactions (Table 1). The
numbers of side-chain contacts, hCi, and HBs, hNhbi, are
reduced approximately in half (to 30.0 and 3.7, respec-
tively). However, little difference is observed in the numbers
of intrapeptide interactions (side-chain contacts and HBs) in
the tetramer and dimer (Table 1). As in the tetramer, pHBs
are largely absent in the dimer (hNphbiz 0.4). The distribu-
tions of interpeptide interactions in Ab oligomers, including
the formation of parallel and antiparallel side chain contacts,
are analyzed in the Supporting Material. It is also instructive
to compare the intrapeptide interactions in the oligomers
with those formed in the monomeric Ab. At 360 K, the
monomer contains hCii z 32.2 side-chain contacts and
hNihbiz 14.1 HBs (Table 1).
The average fractions of b-strand and helix structure, hSti
and hHti, in Ab tetramer are 0.39 and 0.20 (Table 1). The
secondary structure distributions for the dimer and mono-
mer were reported in our previous studies (34,47). Using
those findings, the changes in the b and helix structure in
the tetramer with respect to the dimer are DSt–d ¼ hSti –
hSdi ¼ 0.02 and DHt–d ¼ hHti – hHdi ¼ –0.01 (where hSdi
and hHdi are the b-strand and helix fractions in the dimer
from Table 1). Similarly, using the b-strand and helix frac-
tions in the monomer hSmi and hHmi (Table 1), the changes
in the secondary structure in the tetramer with respect to
the monomer are DSt–m ¼ hSti – hSmi ¼ 0.15 and DHt–m ¼
hHti – hHmi ¼ –0.12. Fig. 3 a presents the distribution of
secondary structure, hSt(i)i and hHt(i)i, in Ab tetramer and
compares it with the dimer and monomer distributions
(34,47). Not only the fractions hSi and hHi but also the
distributions hS(i)i and hH(i)i for the tetramer and dimer
are almost identical. For example, compared to the dimer,
the change in the tetramer b-fraction in the Nt region is
DSt–d(Nt) ¼ hSt(Nt)i – hSd(Nt)i ¼ 0.01, whereas the change
in the Ct is DSt–d(Ct)¼ 0.02. According to Table 1 in the Nt,
the helix fraction changes by DHt–d(Nt) ¼ hHt(Nt)i –
hHd(Nt)i ¼ –0.01 and the same change is observed in the
Ct (DHt–d(Ct) ¼ –0.01). In contrast, Fig. 3 a implicates
profound differences in the secondary structure distributionsBiophysical Journal 99(6) 1949–1958between the tetramer andmonomer. Specifically, the changes
in the b-content in the Nt and Ct regions areDSt–m(Nt)¼ 0.20
andDSt–m(Ct)¼ 0.09 (Table 1). For the helix fractions we get
DHt–m(Nt) ¼ –0.20 and DHt–m(Ct) ¼ –0.05 (Table 1).
Additional information concerning the secondary struc-
ture propensities follows from the distributions of b-strand
and helix lengths. Fig. 3 b displays the distributions of
the number of residues hN(Ls)i in the b-strand fragments
of the length Ls. Consistent with the enhanced b-content
in Ab tetramers and dimers, long b-strands occur more
frequently in the oligomers than in the monomer. For
example, the average number of residues participating in
long b-strands (Ls R 3) is 4.9 for the tetramer, 4.4 for the
dimer, and 2.9 for the monomer. (Because hN(Ls)i is a ther-
mally weighted quantity, it may be smaller or larger than Ls
depending on the probability of occurrence of the strands of
the length Ls. Same argument applies to hN(Lh)i.) Fig. 3 b
reveals that the tetramer and dimer hN(Ls)i distributions
are similar, but both differ from the monomer distribution.
As an illustration, consider hN(Ls)i for Ls ¼ 4. The number
of residues involved in the four-residue strands in the
tetramer is just 10% larger than in the dimer, but it exceeds
threefold the hN(Ls ¼ 4)i value for the monomer. The inset
to Fig. 3 b shows the numbers of residues hN(Lh)i in helix
fragments of the length Lh. Similar to hN(Ls)i, the distribu-
tions of helices in the tetramer and dimer are in close agree-
ment. For example, the average number of residues found
in ‘‘long’’ helices (Lh R 4) is 1.9 for the tetramer and 2.0
for the dimer. Therefore, Fig. 3, a and b, implicate nearly
identical distributions of the secondary structure in the
tetramer and dimer, both of which are different from the
monomeric one.
Finally, we probe the secondary structure propensities by
computing the free energy landscapes for Ab oligomers and
monomers. Fig. 3 c shows the free energies F(S) for the
three Ab species as a function of the fraction of residues
in the b-strand conformation S. The b-structure is most
stable in the tetramer (DFt ¼ –8.6RT) and dimer (DFd ¼
–7.8RT). Both oligomer profiles F(S) reveal a broad, almost
flat minimum spanning the range of S values from ~0.2 to
0.6. In contrast, the monomer profile computed earlier
(34) is shifted to smaller S and more shallow. As a result,
ab
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FIGURE 3 (a) The fractions of helix hH(i)i and b-strand hS(i)i structure
sampled by residues i in Ab10–40 tetramer (solid circles), dimer (shaded
circles), and monomer (open circles). (b) Distribution of the numbers of
residues hN(Ls)i involved in b-strand fragments of the length Ls. The data
for tetramer, dimer, and monomer are shown by open, shaded, and solid
bars. (Inset) Distribution of the numbers of residues hN(Lh)i involved in
helix fragments of the length Lh. The data for tetramer and dimer are shown
by shaded and open bars. (c) Free energy F(S) of Ab10–40 peptide as a
Conformational Ensembles of Ab Oligomers 1953the free energy of monomeric b structure is DFm ¼ –5.6RT.
Therefore, if the free energy of tetramer b-structure is
merely DDFt–d ¼ –0.8RT lower than in the dimer, the free
energy difference increases to DDFt–m ¼ –3.0RT when
tetramer is compared to the monomer.Conformational clusters of Ab oligomers and
monomers
To map the conformational distributions we apply the clus-
tering procedure to the equilibrium structures of Ab mono-
mers, dimers, and tetramers (see Methods, Tables 2–4, and
Fig. 4). In this section, we first describe the conformational
clusters of Ab peptides in the tetramer. The dimer and
monomer clusters are then compared with the tetramer
ones. There are three major conformational clusters in the
tetramer, T1–T3, which together comprise 88% of all struc-
tures (Fig. 4). The distinctive feature of the most populated
cluster T1 is the large fraction of residues in b-strand
conformation, which is evenly present in the Nt and Ct
regions, and the low helix content (S ¼ 0.46 vs. H ¼ 0.14,
Table 2). This cluster is characterized by the largest numbers
of interpeptide interactions (C¼ 60.9 and Nhb¼ 8.2) and the
smallest number of intrapeptide HBs (Nihb ¼ 5.2). Due to
elevated b content, T1 is referred to as b-structure cluster.
In contrast to T1, the cluster T2 has almost equal fractions
of residues sampling b-strand and helix states (S ¼ 0.29
and H ¼ 0.30, Table 2). The helix structure localized in
the Nt (H(Nt) ¼ 0.52) exceeds the b-fraction (S(Nt) ¼
0.16) threefold (Table 2). In T2 there are fewer interpeptide
interactions compared to T1 as the number of interpeptide
contacts C is reduced almost 20% (to 51.0) and the number
of interpeptide HBs is halved (to 4.8). However, compared
to the T1 the number of intrapeptide HBs in the T2 is
doubled (to 10.8). Consequently, we refer to T2 as helical
cluster. The third cluster T3 resembles T2, but has lower
helix content, especially in the Nt, where the helix fraction
is reduced by a factor of 1.6 to H(Nt)¼ 0.32. The cluster T3
has also low b-content in the Ct, which is reduced almost
twofold compared to T1 or T2. Because T3 forms as
much intrapeptide interactions as T2, it represents collapsed
Ab conformations. In all the clusters T1–T3, the Nt is the
main aggregation interface. The ratio of the numbers of in-
terpeptide contacts formed by the Nt and Ct, C(Nt)/C(Ct), is
the largest in T3 (2.6) followed by T1 (2.0) and is the small-
est in T2 (1.6).function of the fraction of residues in the b-strand conformation S: tetramer
(solid circles), dimer (shaded circles), and monomer (open circles). The
free energy of b structure is DF ¼ Fb – F(S ¼ 0), where Fb is obtained
by integrating over the S states, for which F(S) % Fmin þ 1.0RT and Fmin
is the minimum in F(S). The free energy F(S) is computed using multiple
histogram method (46). This figure suggests that the secondary structure
distributions in the tetramers and dimers are similar, but differ sharply
from that in the monomer. The plots are computed at 360 K.
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TABLE 2 Structural clusters in Ab10–40 tetramer
Cluster p* Sy Hz Cx (C(Nt), C(Ct)){ Nhb
k Nihb**
T1 0.46 0.46 (0.48,0.47) 0.14 (0.21,0.09) 60.9 (33.0,16.4) 8.2 5.2
T2 0.23 0.29 (0.16,0.46) 0.30 (0.52,0.10) 51.0 (26.0,16.4) 4.8 10.8
T3 0.19 0.33 (0.37,0.27) 0.23 (0.32,0.19) 52.6 (31.1,11.9) 5.3 10.7
*Fraction of structures included in the cluster, i.e., occurrence probability.
yFractions of b-structure in Ab peptide and in the Nt and Ct terminals (in parentheses).
zFractions of helix in Ab peptide and in the Nt and Ct terminals (in parentheses).
xNumber of interpeptide contacts formed by a peptide in oligomer.
{Numbers of interpeptide contacts formed by the Nt and Ct sequence regions.
kNumber of interpeptide HBs formed by a peptide in oligomer.
**Number of intrapeptide HBs in a peptide.
1954 Kim et al.Similar to the tetramer, there are three main clusters in the
dimer, D1–D3, which together represent 91% of structures
(Table 3 and Fig. 4). The b-structure cluster D1 is almost
identical to T1. The cluster D2, which features elevated
helix structure in the Nt, resembles the tetramer T2. It
follows from Tables 2 and 3 that similarity between the
tetramer T1-T2 and dimer D1-D2 clusters is manifested in
the distributions of secondary structure and intrapeptide
interactions. As expected for the dimer, D1 and D2 form
fewer interpeptide interactions compared to the tetramer.
Finally, there are close parallels between the collapsed clus-
ters D3 in the dimer and T3 in the tetramer. As T3, the dimer
cluster displays extensive intrapeptide interactions and the
low Nt helix and Ct strand contents compared to those
seen in D2. Table 3 shows that matching dimer and tetramer
clusters have almost identical occurrence probabilities.
As for the tetramer, a polarized aggregation interface is
observed in all dimer clusters. The largest ratio C(Nt)/C
(Ct) ¼ 2.2 is found in the collapsed cluster D3, whereas
the helix D2 has the lowest ratio (1.7).
The monomeric structures partition into two main clus-
ters, M1 and M2, which combined represent 88% of Ab
conformations (Table 4 and Fig. 4). The most populated
cluster M1 resembles the dimer D2 and tetramer T2 clusters.
It features similar b-strand and helix fractions (S¼ 0.26 and
H ¼ 0.31). With the helix structure being localized in the Nt
region, H(Nt) in M1 is identical to the respective values for
D2 and T2 in Tables 2 and 3. Furthermore, the number of
intrapeptide HBs in M1 (Nihb ¼ 12.9) is similar to Nihb in
D2 and T2 (Tables 2 and 3). The second cluster M2, whichTABLE 3 Structural clusters in Ab10–40 dimer
Cluster p* Sy Hz
D1 0.47 0.44 (0.46,0.45) 0.15 (0.22,0.09)
D2 0.25 0.27 (0.15,0.42) 0.31 (0.52,0.12)
D3 0.19 0.29 (0.32,0.23) 0.26 (0.36,0.20)
*Fraction of structures included in the cluster, i.e., occurrence probability.
yFractions of b-structure in Ab peptide and in the Nt and Ct terminals (in paren
zFractions of helix in Ab peptide and in the Nt and Ct terminals (in parenthese
xNumber of interpeptide contacts formed by a peptide in oligomer.
{Numbers of interpeptide contacts formed by the Nt and Ct sequence regions.
kNumber of interpeptide HBs formed by a peptide in oligomer.
**Number of intrapeptide HBs in a peptide.
Biophysical Journal 99(6) 1949–1958is less populated than M1, differs from all dimer or tetramer
clusters. It is characterized by elevated helix structure
(H ¼ 0.37) and suppressed b-structure (S ¼ 0.17). The
distinctive feature of all-helix M2 is the large number of
intrapeptide HBs (Nihb ¼ 17.4), which is increased ~50%
compared to M1.DISCUSSION
Conformations of Ab peptides in dimers
and tetramers are similar
Our REMD simulations suggest that the conformational
ensembles of Ab peptides in the dimers and tetramers
are similar. This conclusion is based on the following
observations.
Ab peptides in the dimers and tetramers form similar
amount of intrapeptide interactions. For example, the differ-
ences in the numbers of intrapeptide HBs hNihbi and side-
chain contacts hCii are merely 18% and 6% (Table 1).
Although there are more interpeptide interactions formed
in the tetramer than in the dimer, their distributions in both
oligomers are very similar (see the Supporting Material).
Indeed, the number of contacts between the sequence
regions s1 and s2 (¼ Nt, Ct) in the dimer can be obtained by
rescaling those formed in the tetramer, i.e., hCd(s1, s2)i z
0.6 hCt(s1, s2)i (see the Supporting Material). More impor-
tantly, the Nt terminal forms two-thirds of all interpeptide
interactions in the tetramer and dimer (hC(Nt)iz 2 hC(Ct)i),
implicating the Nt region as the main aggregation interfaceCx (C(Nt), C(Ct)){ Nhb
k Nihb**
33.1 (17.5,9.5) 4.7 6.9
28.8 (15.3,8.8) 2.9 11.7
27.3 (15.5,7.1) 2.7 13.1
theses).
s).
TABLE 4 Structural clusters in Ab10–40 monomer
Cluster p* Sy Hz Nihb
x
M1 0.55 0.26 (0.16,0.35) 0.31 (0.52,0.15) 12.9
M2 0.33 0.17 (0.13,0.24) 0.37 (0.54,0.21) 17.4
*Fraction of structures included in the cluster, i.e., occurrence probability.
yFractions of b-structure in Ab peptide and in the Nt and Ct terminals
(in parentheses).
zFractions of helix in Ab peptide and in the Nt and Ct terminals (in paren-
theses).
xNumber of intrapeptide HBs in a peptide.
Conformational Ensembles of Ab Oligomers 1955in Ab oligomers. It is also noteworthy that there are few
parallel HBs in the dimers and tetramers, which are the hall-
mark of fibril structure (17). No preference for parallel or
antiparallel aggregation interface is observed in Ab oligo-
mers (see the Supporting Material).
There are similarities in the secondary structure. For
example, the fractions of b-strand and helix structure inβ T1
46%
helix T2 
23% c
Tetramer 
helix D2 
25%
Dimer
Monomer 
all-helix M2 
 33% 
helix M1 
55%
β D1 
47%the tetramer and dimer differ by 5% (Table 1). Fig. 3 a
demonstrates that the distributions of secondary structure
along Ab sequence are nearly identical in both oligomers.
The fractions of b-strand and helix structure in the Nt and
Ct do not differ by >5% (the exception is hH(Ct)i being
different by ~10%). Furthermore, as illustrated in Fig. 3 b
the distributions of b-strands and helix fragments in the
tetramer and dimer are similar. Finally, Fig. 3 c demon-
strates that the free energy of the b-strand structure in the
tetramer is only marginally lower than in the dimer
(DDFt–d ( RT).
Computation of conformational clusters provides the
most compelling evidence for the similarity of the dimer
and tetramer conformational ensembles (Tables 2 and 3
and Fig. 4). The three conformational clusters T1–T3 in
the tetramer match the clusters D1–D3 in the dimer. Impor-
tantly, not only are the structural characteristics of these
clusters similar, but so are the probabilities of theirollapsed T3 
19%
collapsed D3
19%
FIGURE 4 Conformational ensembles ofAb10–40
peptides in monomers, dimers, and tetramers at
360 K. The figure shows typical peptide structures
from populated conformational clusters. Shaded
arrows indicate similarities between the clusters.
The cluster characteristics are given in Tables 2–4.
The N- and C-terminals are colored in shades
of red and yellow, respectively. The picture demon-
strates that the conformational ensembles of mono-
mers and oligomers are distinct, whereas Ab10–40
peptides in the dimers and tetramers sample similar
structural distributions. The structures are visualized
using Chimera (50).
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dimer comprise ~90% of Ab conformations, we suggest
that, at least for small oligomers, Ab conformational ensem-
bles are independent of the oligomer order n.
Our findings indicate that in contrast to monomers the
b-structure in Ab oligomers occurs more frequently than
the helix conformations. The enhancement of b-structure
in oligomers is driven by the formation of interpeptide inter-
actions, mostly by side-chain contacts with minor contribu-
tion from HBs (Table 1). Most b-strands in the oligomers are
short (Fig. 3 b) and, because they form few parallel HBs,
ordered b-sheets are rare. Therefore, the oligomer structure
contains few elements of fibril-like conformations.FIGURE 5 The experimental b content Sexp(n) (20) (triangles) and the
in silico b content hS(n)i (open circles) are plotted as a function of the in-
versed oligomer order n. The plot suggests that simulations reproduce fairly
well experimental estimates of secondary structure.Conformations of Ab peptides in oligomers
and monomers are distinct
It follows from our results that the conformational
ensembles of Ab oligomers and monomers are different.
Following the same approach used for comparing the dimers
and tetramers, we identify the following differences.
Ab monomers and oligomers differ with respect to the
distribution of intrapeptide interactions. For example, com-
pared to the tetramer the number of intrapeptide HBs in the
monomer increases 80% coupled with 25% increase in the
number of side-chain contacts (Table 1).
The secondary structures in Ab monomers and oligomers
are different. The fractions of b-strand and helix structure in
the tetramer are 40% larger and 60% lower, respectively,
than in the monomer (Table 1). Fig. 3 a shows that there
are striking dissimilarities in the distributions of secondary
structure along Ab sequence. For example, the fraction of
b-strand in the Nt regions of the tetramer hSt(Nt)i exceeds
that for the monomer hSm(Nt)i by more than twofold. The
distributions of b-strands in the tetramer and monomer
also differ considerably (Fig. 3 b and Results). Consistent
with these findings indicating the enhancement of b content
in the oligomers, the free energy of the b-strand structure in
the monomer is z3.0RT higher than in the tetramer.
The analysis of conformational clusters reveals that the
oligomer and monomer conformational ensembles are
different (Tables 2–4 and Fig. 4). The monomer distribution
contains only two clusters, of which only one, M1, bears
similarity to the oligomer clusters T2 or D2. Therefore,
the monomer samples significant fraction (~0.3) of confor-
mations (the all-helix cluster M2), which are not seen in
the oligomers. Conversely, the oligomers contain the clus-
ters (T1,T3 and D1,D3) with elevated b-strand content
(S T 0.3) not observed in the monomers. For example, in
T1 and D1 the fraction of b structure approaches 0.5 in
both sequence regions Nt and Ct.
In summary, the key difference between the conforma-
tional ensembles of monomers and oligomers is the increase
in b-structure in the oligomers occurring together with the
loss of intrapeptide interactions. These changes are mani-Biophysical Journal 99(6) 1949–1958fested by the disappearance of the monomeric cluster
M2, emergence of the new oligomeric clusters T1,T3 (or
D1,D3), and decrease in the statistical weight of the cluster
M1 (D2,T2) (Tables 2–4 and Fig. 4).Comparing experimental and computational Ab
conformational ensembles
Recent experiments employing photoinduced chemical
crosslinking technique probed the structures of Ab aggre-
gated species (20). The CD analysis of secondary structure
revealed that the most profound conformational change
occurs upon the conversion of monomers into dimers.
Table 1 shows that this conversion results in the increase
in the b-content from Sm
exp ¼ 0.24 (monomer) to Sdexp ¼
0.39 (dimer). The difference in the fractions of b-structure
in the dimer and tetramer is relatively small (Sd
exp ¼ 0.39
vs. St
exp ¼ 0.45 in Table 1). Therefore, monomer-to-dimer
conversion results inz60% increase in b-fraction, whereas
there is only 15% additional increase in the b-structure upon
forming the tetramer.
To test the accuracy of our simulations, Fig. 5 compares
the experimental and in silico fractions of b-structure.
This comparison is facilitated by including the data for
Ab fibril peptides determined experimentally or computed
in our recent studies using the same simulation model
(Table 1) (20,42). Fig. 5 shows that the experimental and
computational b contents Sexp(n) and hS(n)i are in good
agreement for all available values of oligomer order n.
This lends support to the in silico conformational ensembles
obtained in our study.
It should be mentioned that CHARMM19þSASA model
predicts higher helix content in Ab species (monomers
through tetramers) than the experiments (20). There are
two possible reasons for this discrepancy.
Conformational Ensembles of Ab Oligomers 1957First, we use truncated Ab10–40 peptides, in which first
nine N-terminal residues are deleted. Our previous study
(34) has shown that the truncation results in 19% increase
in the fraction of helix residues in the monomers (from
0.27 in Ab1–40 to 0.32 in Ab10–40).
Second, we cannot rule out that the SASA implicit
solvent model overestimates the fraction of helix structure
in Ab species due to approximate treatment of hydration
effects. Hence, further studies will be needed to determine
the exact cause of this discrepancy.
It is also important to comment on the experimental and
in silico oligomer-size distributions. A continuous distribu-
tion of Ab species, from monomers to tetramers, is observed
in the experiments (20). In our simulations, Ab dimers or
tetramers are formed with the probability ~1.0. To resolve
this difference, one needs to recall that the in vitro experi-
ments probing Ab aggregation are performed at micromolar
concentrations, whereas a millimolar Ab concentration is
used in our study to accelerate sampling of aggregated
states. Consequently, in simulations the thermodynamic
equilibrium is expected to shift to higher order oligomers.
Qualitatively similar changes in the secondary structure
were observed in the oligomers formed by a-synuclein
(48). The Raman spectroscopy showed that the small
a-synuclein oligomers possess significant amount of helix
structure (47%), which decreases upon aggregation progres-
sion. Simultaneously, the fraction of b-sheet conformations
grows from 29% in small oligomers to 54% in protofila-
ments. Therefore, the conversion of helix structure into
b in the oligomers is likely to be a generic feature of aggre-
gation.
A computational study relevant to our simulations has
investigated the oligomers formed by human islet amyloid
polypeptide (hIAPP) (49). It has been shown that hIAPP
trimers do not contain parallel or antiparallel in-registry
b-structure characteristic of seeded hIAPP fibrils. Moreover,
in agreement with our data, implicit solvent MD study of
Ab1–39 dimer also found no evidence of fibril-like confor-
mations (30). Those findings are qualitatively consistent
with our results on Ab oligomers.SUPPORTING MATERIAL
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